Authors' objectives: Nicotine is a highly addictive drug that is found in all tobacco products. Around 50% of all regular tobacco smokers will eventually die from smoking-related causes. Smoking is becoming less popular in the UK but still remains a leading cause of death and disease. Voke 0.45mg inhaler is a new nicotine replacement device for people who want to reduce, replace, or stop smoking. It is a rechargable stick that is designed to look and feel like a traditional tobacco cigarette. It works in a similar way to an asthma inhaler, delivering nicotine as and when required to help satisfy nicotine cravings. Voke 0.45mg inhaler has been studied to see how well it works in comparison to other nicotine replacement therapies. Voke 0.45mg inhaler has been licensed for use in the UK, and will provide a new treatment option for smokers who want to reduce, replace, or stop smoking.

Project Status: Completed

Year Published: 2016

URL for published report: http://www.hsric.nihr.ac.uk/topics/voke-0-45mg-inhaler-for-smoking-cessation-first-line/

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: England, United Kingdom

Organisation Name: NIHR Horizon Scanning Centre

Contact Address: The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269

Contact Name: c.packer@bham.ac.uk

Contact Email: c.packer@bham.ac.uk

Copyright: NIHR Horizon Scanning Research&Intelligence Centre (NIHR HSRIC)